Group One Trading’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Group One Trading’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1	Closed	-$10K	–	5044
2015 Q4	$10K	Hold	1	–	–	﹤0.01%	4193
2015 Q3	$11K	Buy	+1	New	+$25.7K	﹤0.01%	4274

Other funds holding YTEN

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's YTEN Position: Q3 2017 in Review

Group One Trading held its Yield10 Bioscience, Inc. Common Stock (YTEN) position steady in Q3 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5258.

Group One Trading first reported a position in YTEN in Q3 2015 and has held it in 1 quarter since. The position peaked at $8K in Q3 2015. 5 funds tracked by Wall St. Rank hold YTEN as of Q3 2017.

Group One Trading held 0 shares of Yield10 Bioscience, Inc. Common Stock worth $0 as of Q3 2017.
Group One Trading left its Yield10 Bioscience, Inc. Common Stock share count unchanged in Q3 2017.
Yield10 Bioscience, Inc. Common Stock made up ﹤0.01% of Group One Trading's portfolio in Q3 2017, its #5258 holding.
Group One Trading first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2015 and has held it in 1 quarter since.
Group One Trading's Yield10 Bioscience, Inc. Common Stock position peaked at $8K in Q3 2015.
5 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.